In vitro profiling of the metabolism and drug–drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes and recombinant human CYP - Yamane, M; Kawashima, K; Yamaguchi, K (Xenobiotica, 2015)
et al.